These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 25604253)

  • 1. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
    Bladen CL; Salgado D; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lahdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Viswanathan V; Bayat F; Buccella F; Kimura E; Koeks Z; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Zimowski J; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Jeannet PY; Joncourt F; Díaz-Manera J; Gallardo E; Karaduman AA; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Bellgard MI; Kirschner J; Flanigan KM; Straub V; Bushby K; Verschuuren J; Aartsma-Rus A; Béroud C; Lochmüller H
    Hum Mutat; 2015 Apr; 36(4):395-402. PubMed ID: 25604253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genetic characteristics of dystrophinopathies in China.
    Ma P; Zhang S; Zhang H; Fang S; Dong Y; Zhang Y; Hao W; Wu S; Zhao Y
    Orphanet J Rare Dis; 2018 Jul; 13(1):109. PubMed ID: 29973226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China.
    Wang DN; Wang ZQ; Yan L; He J; Lin MT; Chen WJ; Wang N
    Neuromuscul Disord; 2017 Aug; 27(8):715-722. PubMed ID: 28318817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase.
    Tuffery-Giraud S; Béroud C; Leturcq F; Yaou RB; Hamroun D; Michel-Calemard L; Moizard MP; Bernard R; Cossée M; Boisseau P; Blayau M; Creveaux I; Guiochon-Mantel A; de Martinville B; Philippe C; Monnier N; Bieth E; Khau Van Kien P; Desmet FO; Humbertclaude V; Kaplan JC; Chelly J; Claustres M
    Hum Mutat; 2009 Jun; 30(6):934-45. PubMed ID: 19367636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.
    Okubo M; Noguchi S; Hayashi S; Nakamura H; Komaki H; Matsuo M; Nishino I
    Hum Genet; 2020 Feb; 139(2):247-255. PubMed ID: 31919629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.
    Aartsma-Rus A; Fokkema I; Verschuuren J; Ginjaar I; van Deutekom J; van Ommen GJ; den Dunnen JT
    Hum Mutat; 2009 Mar; 30(3):293-9. PubMed ID: 19156838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A different spectrum of DMD gene mutations in local Chinese patients with Duchenne/Becker muscular dystrophy.
    Lo IF; Lai KK; Tong TM; Lam ST
    Chin Med J (Engl); 2006 Jul; 119(13):1079-87. PubMed ID: 16834926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The First Comprehensive Cohort of the Duchenne Muscular Dystrophy in Iranian Population: Mutation Spectrum of 314 Patients and Identifying Two Novel Nonsense Mutations.
    Zamani G; Hosseini Bereshneh A; Azizi Malamiri R; Bagheri S; Moradi K; Ashrafi MR; Tavasoli AR; Mohammadi M; Badv RS; Ghahvechi Akbari M; Heidari M
    J Mol Neurosci; 2020 Oct; 70(10):1565-1573. PubMed ID: 32436198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
    Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
    PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation Spectrum of Dystrophinopathies in India: Implications for Therapy.
    Kohli S; Saxena R; Thomas E; Singh K; Bijarnia Mahay S; Puri RD; Verma IC
    Indian J Pediatr; 2020 Jul; 87(7):495-504. PubMed ID: 32358784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy.
    Viggiano E; Picillo E; Passamano L; Onore ME; Piluso G; Scutifero M; Torella A; Nigro V; Politano L
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene.
    Flanigan KM; Dunn DM; von Niederhausern A; Soltanzadeh P; Howard MT; Sampson JB; Swoboda KJ; Bromberg MB; Mendell JR; Taylor LE; Anderson CB; Pestronk A; Florence JM; Connolly AM; Mathews KD; Wong B; Finkel RS; Bonnemann CG; Day JW; McDonald C; ; Weiss RB
    Hum Mutat; 2011 Mar; 32(3):299-308. PubMed ID: 21972111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
    Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
    Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of Japanese patients to development of antisense therapy for DMD.
    Matsuo M; Takeshima Y; Nishio H
    Brain Dev; 2016 Jan; 38(1):4-9. PubMed ID: 26094594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?
    Yokota T; Duddy W; Echigoya Y; Kolski H
    Expert Opin Biol Ther; 2012 Sep; 12(9):1141-52. PubMed ID: 22650324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan.
    Okubo M; Goto K; Komaki H; Nakamura H; Mori-Yoshimura M; Hayashi YK; Mitsuhashi S; Noguchi S; Kimura E; Nishino I
    Orphanet J Rare Dis; 2017 Aug; 12(1):149. PubMed ID: 28859693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.
    Bello L; Morgenroth LP; Gordish-Dressman H; Hoffman EP; McDonald CM; Cirak S;
    Neurology; 2016 Jul; 87(4):401-9. PubMed ID: 27343068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B; Wood MJA; Roberts TC
    RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.